RadNet parent to merge with DIS

Article

Two Los Angeles imaging services firms are planning to merge ina move that will increase center consolidation in California.Primedex Health Systems, the parent of imaging firm RadNet Managementand management service organization Future Diagnostics, has

Two Los Angeles imaging services firms are planning to merge ina move that will increase center consolidation in California.Primedex Health Systems, the parent of imaging firm RadNet Managementand management service organization Future Diagnostics, has agreedto merge with imaging services provider Diagnostic Imaging Services.

RadNet operates 19 imaging centers in California, while DiagnosticImaging Services runs 10 imaging centers in Southern California,as well as 15 ultrasound labs and 13 mobile ultrasound units.

Primedex already owns 31% of DIS common stock, which it purchasedin March. Under the merger deal, Primedex stockholders would receiveone share of DIS stock for every 1.33 shares of Primedex stock.The merged company would have combined annual gross revenues of$135 million.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.